XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ (1,177) $ 1   $ 9,874 $ (11,052)
Beginning Balance (Shares) at Dec. 31, 2020   8,908,600 2,324,479    
Exercise of stock options 6     6  
Exercise of stock options (in shares)     50,000    
Stock-based compensation expense 10     10  
Net loss (1,356)       (1,356)
Ending Balance at Mar. 31, 2021 (2,517) $ 1   9,890 (12,408)
Ending Balance (Shares) at Mar. 31, 2021   8,908,600 2,374,479    
Beginning Balance at Dec. 31, 2020 (1,177) $ 1   9,874 (11,052)
Beginning Balance (Shares) at Dec. 31, 2020   8,908,600 2,324,479    
Net loss (4,770)        
Ending Balance at Sep. 30, 2021 (5,792) $ 1   10,029 (15,822)
Ending Balance (Shares) at Sep. 30, 2021   8,908,600 2,833,958    
Beginning Balance at Mar. 31, 2021 (2,517) $ 1   9,890 (12,408)
Beginning Balance (Shares) at Mar. 31, 2021   8,908,600 2,374,479    
Stock-based compensation expense 8     8  
Net loss (1,094)       (1,094)
Ending Balance at Jun. 30, 2021 (3,603) $ 1   9,898 (13,502)
Ending Balance (Shares) at Jun. 30, 2021   8,908,600 2,374,479    
Exercise of stock options 56     56  
Exercise of stock options (in shares)     346,979    
Issuance of common stock (in shares)     112,500    
Issuance of warrants 52     52  
Stock-based compensation expense 23     23  
Net loss (2,320)       (2,320)
Ending Balance at Sep. 30, 2021 (5,792) $ 1   10,029 (15,822)
Ending Balance (Shares) at Sep. 30, 2021   8,908,600 2,833,958    
Beginning Balance at Dec. 31, 2021 13,272   $ 1 32,817 (19,546)
Beginning Balance (Shares) at Dec. 31, 2021     9,715,234    
Stock-based compensation expense 61     61  
Net loss (2,240)       (2,240)
Ending Balance at Mar. 31, 2022 11,093   $ 1 32,878 (21,786)
Ending Balance (Shares) at Mar. 31, 2022     9,715,234    
Beginning Balance at Dec. 31, 2021 $ 13,272   $ 1 32,817 (19,546)
Beginning Balance (Shares) at Dec. 31, 2021     9,715,234    
Exercise of stock options (in shares) 56,250        
Net loss $ (7,842)        
Ending Balance at Sep. 30, 2022 5,772   $ 1 33,159 (27,388)
Ending Balance (Shares) at Sep. 30, 2022     9,677,734    
Beginning Balance at Mar. 31, 2022 11,093   $ 1 32,878 (21,786)
Beginning Balance (Shares) at Mar. 31, 2022     9,715,234    
Repurchase of common stock (in shares)     (93,750)    
Stock-based compensation expense 112     112  
Net loss (3,018)       (3,018)
Ending Balance at Jun. 30, 2022 8,187   $ 1 32,990 (24,804)
Ending Balance (Shares) at Jun. 30, 2022     9,621,484    
Exercise of stock options 56     56  
Exercise of stock options (in shares)     56,250    
Stock-based compensation expense 113     113  
Net loss (2,584)       (2,584)
Ending Balance at Sep. 30, 2022 $ 5,772   $ 1 $ 33,159 $ (27,388)
Ending Balance (Shares) at Sep. 30, 2022     9,677,734